Journal article
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer
Abstract
Importance: Decipher (Decipher Biosciences Inc) is a genomic classifier (GC) developed to estimate the risk of distant metastasis (DM) after radical prostatectomy (RP) in patients with prostate cancer.
Objective: To validate the GC in the context of a randomized phase 3 trial.
Authors
Feng FY; Huang H-C; Spratt DE; Zhao S; Sandler HM; Simko JP; Davicioni E; Nguyen PL; Pollack A; Efstathiou JA
Journal
JAMA Oncology, Vol. 7, No. 4, pp. 544–552
Publisher
American Medical Association (AMA)
Publication Date
April 1, 2021
DOI
10.1001/jamaoncol.2020.7671
ISSN
2374-2437